David S. Peabody - Publications

Affiliations: 
Biomedical Sciences University of New Mexico, Albuquerque, NM, United States 
Area:
Biomedical Engineering, Molecular Biology, Nanoscience

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ronsard L, Yousif AS, Peabody J, Okonkwo V, Devant P, Mogus AT, Barnes RM, Rohrer D, Lonberg N, Peabody D, Chackerian B, Lingwood D. Engineering an Antibody V Gene-Selective Vaccine. Frontiers in Immunology. 12: 730471. PMID 34566992 DOI: 10.3389/fimmu.2021.730471  0.321
2021 Peabody DS, Peabody J, Bradfute SB, Chackerian B. RNA Phage VLP-Based Vaccine Platforms. Pharmaceuticals (Basel, Switzerland). 14. PMID 34451861 DOI: 10.3390/ph14080764  0.336
2020 Warner NL, Linville AC, Core SB, Moreno B, Pascale JM, Peabody DS, Chackerian B, Frietze KM. Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum. Viruses. 12. PMID 33008118 DOI: 10.3390/v12101114  0.301
2020 Joyner JA, Daly SM, Peabody J, Triplett KD, Pokhrel S, Elmore BO, Adebanjo D, Peabody DS, Chackerian B, Hall PR. Vaccination with VLPs Presenting a Linear Neutralizing Domain of Hla Elicits Protective Immunity. Toxins. 12. PMID 32664481 DOI: 10.3390/Toxins12070450  0.371
2020 Chackerian B, Peabody DS. Factors That Govern the Induction of Long-Lived Antibody Responses. Viruses. 12. PMID 31936163 DOI: 10.3390/V12010074  0.304
2020 Frietze KM, Core SB, Linville A, Chackerian B, Peabody DS. Assessing Antibody Specificity in Human Serum Using Deep Sequence-Coupled Biopanning. Methods in Molecular Biology (Clifton, N.J.). 2070: 157-171. PMID 31625095 DOI: 10.1007/978-1-4939-9853-1_9  0.366
2018 Ntumngia FB, Thomson-Luque R, Galusic S, Frato G, Frischmann S, Peabody DS, Chackerian B, Ferreira MU, King CL, Adams JH. Identification and immunological characterization of the ligand domain of Plasmodium vivax reticulocyte binding protein 1a. The Journal of Infectious Diseases. PMID 29741629 DOI: 10.1093/Infdis/Jiy273  0.326
2017 Daly SM, Joyner JA, Triplett KD, Elmore BO, Pokhrel S, Frietze KM, Peabody DS, Chackerian B, Hall PR. VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation. Scientific Reports. 7: 637. PMID 28377579 DOI: 10.1038/S41598-017-00753-0  0.355
2017 Lino CA, Caldeira JC, Peabody DS. Display of single-chain variable fragments on bacteriophage MS2 virus-like particles. Journal of Nanobiotechnology. 15: 13. PMID 28193211 DOI: 10.1186/S12951-016-0240-7  0.466
2017 Frietze KM, Pascale JM, Moreno B, Chackerian B, Peabody DS. Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses. Plos One. 12: e0171511. PMID 28152075 DOI: 10.1371/Journal.Pone.0171511  0.413
2016 Frietze KM, Peabody DS, Chackerian B. Engineering virus-like particles as vaccine platforms. Current Opinion in Virology. 18: 44-49. PMID 27039982 DOI: 10.1016/J.Coviro.2016.03.001  0.363
2016 Saboo S, Tumban E, Peabody J, Wafula D, Peabody DS, Chackerian B, Muttil P. Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus. Molecular Pharmaceutics. 13: 1646-55. PMID 27019231 DOI: 10.1021/Acs.Molpharmaceut.6B00072  0.371
2015 Caldeira J, Bustos J, Peabody J, Chackerian B, Peabody DS. Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform. Plos One. 10: e0141407. PMID 26516771 DOI: 10.1371/Journal.Pone.0141407  0.47
2015 Crossey E, Frietze K, Narum DL, Peabody DS, Chackerian B. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display. Plos One. 10: e0132560. PMID 26147502 DOI: 10.1371/Journal.Pone.0132560  0.465
2015 Tumban E, Muttil P, Escobar CA, Peabody J, Wafula D, Peabody DS, Chackerian B. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2. Vaccine. 33: 3346-53. PMID 26003490 DOI: 10.1016/J.Vaccine.2015.05.016  0.372
2015 O'Rourke JP, Peabody DS, Chackerian B. Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform. Current Opinion in Virology. 11: 76-82. PMID 25829254 DOI: 10.1016/J.Coviro.2015.03.005  0.402
2014 O'Rourke JP, Daly SM, Triplett KD, Peabody D, Chackerian B, Hall PR. Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway. Plos One. 9: e111198. PMID 25379726 DOI: 10.1371/Journal.Pone.0111198  0.448
2014 Ord RL, Caldeira JC, Rodriguez M, Noe A, Chackerian B, Peabody DS, Gutierrez G, Lobo CA. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein. Malaria Journal. 13: 326. PMID 25135070 DOI: 10.1186/1475-2875-13-326  0.355
2014 Tyler M, Tumban E, Dziduszko A, Ozbun MA, Peabody DS, Chackerian B. Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing. Vaccine. 32: 4267-74. PMID 24962748 DOI: 10.1016/J.Vaccine.2014.06.054  0.376
2014 Tyler M, Tumban E, Peabody DS, Chackerian B. The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine. Biotechnology and Bioengineering. 111: 2398-406. PMID 24917327 DOI: 10.1002/Bit.25311  0.416
2013 Tumban E, Peabody J, Peabody DS, Chackerian B. A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants. Vaccine. 31: 4647-54. PMID 23933337 DOI: 10.1016/J.Vaccine.2013.07.052  0.408
2012 Tumban E, Peabody J, Tyler M, Peabody DS, Chackerian B. VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus. Plos One. 7: e49751. PMID 23185426 DOI: 10.1371/Journal.Pone.0049751  0.413
2012 Epler K, Padilla D, Phillips G, Crowder P, Castillo R, Wilkinson D, Wilkinson B, Burgard C, Kalinich R, Townson J, Chackerian B, Willman C, Peabody D, Wharton W, Brinker JC, et al. Delivery of ricin toxin A-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers Advanced Healthcare Materials. 1: 348-353. PMID 23184753 DOI: 10.1002/Adhm.201200022  0.337
2012 Ashley CE, Carnes EC, Epler KE, Padilla DP, Phillips GK, Castillo RE, Wilkinson DC, Wilkinson BS, Burgard CA, Kalinich RM, Townson JL, Chackerian B, Willman CL, Peabody DS, Wharton W, et al. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers. Acs Nano. 6: 2174-88. PMID 22309035 DOI: 10.1021/Nn204102Q  0.389
2012 Epler K, Padilla D, Phillips G, Crowder P, Castillo R, Wilkinson D, Wilkinson B, Burgard C, Kalinich R, Townson J, Chackerian B, Willman C, Peabody D, Wharton W, Brinker CJ, et al. Targeted Delivery of Protein Toxins: Delivery of Ricin Toxin A-Chain by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Adv. Healthcare Mater. 3/2012) Advanced Healthcare Materials. 1: 241-241. DOI: 10.1002/Adhm.201290013  0.337
2011 Tumban E, Peabody J, Peabody DS, Chackerian B. A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2. Plos One. 6: e23310. PMID 21858066 DOI: 10.1371/Journal.Pone.0023310  0.352
2011 Ashley CE, Carnes EC, Phillips GK, Durfee PN, Buley MD, Lino CA, Padilla DP, Phillips B, Carter MB, Willman CL, Brinker CJ, Caldeira Jdo C, Chackerian B, Wharton W, Peabody DS. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. Acs Nano. 5: 5729-45. PMID 21615170 DOI: 10.1021/nn201397z  0.308
2011 Caldeira JC, Peabody DS. Thermal stability of RNA phage virus-like particles displaying foreign peptides. Journal of Nanobiotechnology. 9: 22. PMID 21609437 DOI: 10.1186/1477-3155-9-22  0.519
2011 Chackerian B, Caldeira Jdo C, Peabody J, Peabody DS. Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles. Journal of Molecular Biology. 409: 225-37. PMID 21501621 DOI: 10.1016/J.Jmb.2011.03.072  0.473
2011 Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, Brown PA, Hanna TN, Liu J, Phillips B, Carter MB, Carroll NJ, Jiang X, Dunphy DR, Willman CL, Petsev DN, ... ... Peabody DS, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nature Materials. 10: 389-97. PMID 21499315 DOI: 10.1038/Nmat2992  0.327
2010 Caldeira Jdo C, Medford A, Kines RC, Lino CA, Schiller JT, Chackerian B, Peabody DS. Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7. Vaccine. 28: 4384-93. PMID 20434554 DOI: 10.1016/J.Vaccine.2010.04.049  0.467
2008 Peabody DS, Manifold-Wheeler B, Medford A, Jordan SK, do Carmo Caldeira J, Chackerian B. Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2. Journal of Molecular Biology. 380: 252-63. PMID 18508079 DOI: 10.1016/J.Jmb.2008.04.049  0.692
2007 Caldeira JC, Peabody DS. Stability and assembly in vitro of bacteriophage PP7 virus-like particles. Journal of Nanobiotechnology. 5: 10. PMID 18039380 DOI: 10.1186/1477-3155-5-10  0.404
2006 Chackerian B, Rangel M, Hunter Z, Peabody DS. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses. Vaccine. 24: 6321-31. PMID 16806604 DOI: 10.1016/J.Vaccine.2006.05.059  0.371
2006 Anderson EA, Isaacman S, Peabody DS, Wang EY, Canary JW, Kirshenbaum K. Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Letters. 6: 1160-4. PMID 16771573 DOI: 10.1021/Nl060378G  0.328
2006 Lima SM, Vaz AC, Souza TL, Peabody DS, Silva JL, Oliveira AC. Dissecting the role of protein-protein and protein-nucleic acid interactions in MS2 bacteriophage stability. The Febs Journal. 273: 1463-75. PMID 16689932 DOI: 10.1111/J.1742-4658.2006.05167.X  0.444
2006 Horn WT, Tars K, Grahn E, Helgstrand C, Baron AJ, Lago H, Adams CJ, Peabody DS, Phillips SE, Stonehouse NJ, Liljas L, Stockley PG. Structural basis of RNA binding discrimination between bacteriophages Qbeta and MS2. Structure (London, England : 1993). 14: 487-95. PMID 16531233 DOI: 10.1016/J.Str.2005.12.006  0.422
2004 Lima SM, Peabody DS, Silva JL, de Oliveira AC. Mutations in the hydrophobic core and in the protein-RNA interface affect the packing and stability of icosahedral viruses. European Journal of Biochemistry / Febs. 271: 135-45. PMID 14686926 DOI: 10.1046/J.1432-1033.2003.03911.X  0.399
2003 Peabody DS. A Viral Platform for Chemical Modification and Multivalent Display. Journal of Nanobiotechnology. 1: 5. PMID 12890286 DOI: 10.1186/1477-3155-1-5  0.418
2003 Anobom CD, Albuquerque SC, Albernaz FP, Oliveira AC, Silva JL, Peabody DS, Valente AP, Almeida FC. Structural studies of MS2 bacteriophage virus particle disassembly by nuclear magnetic resonance relaxation measurements. Biophysical Journal. 84: 3894-903. PMID 12770895 DOI: 10.1016/S0006-3495(03)75117-0  0.326
2002 Lim F, Peabody DS. RNA recognition site of PP7 coat protein. Nucleic Acids Research. 30: 4138-44. PMID 12364592 DOI: 10.1093/Nar/Gkf552  0.453
2002 Spingola M, Lim F, Peabody DS. Recognition of diverse RNAs by a single protein structural framework. Archives of Biochemistry and Biophysics. 405: 122-9. PMID 12176065 DOI: 10.1016/S0003-9861(02)00334-X  0.453
2001 Peabody DS, Al-Bitar L. Isolation of viral coat protein mutants with altered assembly and aggregation properties. Nucleic Acids Research. 29: E113. PMID 11713333 DOI: 10.1093/Nar/29.22.E113  0.379
2001 Powell AJ, Peabody DS. Asymmetric interactions in the adenosine-binding pockets of the MS2 coat protein dimer. Bmc Molecular Biology. 2: 6. PMID 11504563 DOI: 10.1186/1471-2199-2-6  0.432
2001 Lim F, Downey TP, Peabody DS. Translational repression and specific RNA binding by the coat protein of the Pseudomonas phage PP7. The Journal of Biological Chemistry. 276: 22507-13. PMID 11306589 DOI: 10.1074/Jbc.M102411200  0.477
1999 Peabody DS, Chakerian A. Asymmetric contributions to RNA binding by the Thr45 residues of the MS2 coat protein dimer Journal of Biological Chemistry. 274: 25403-25410. PMID 10464269 DOI: 10.1074/Jbc.274.36.25403  0.468
1998 Hirao I, Spingola M, Peabody D, Ellington AD. The limits of specificity: an experimental analysis with RNA aptamers to MS2 coat protein variants. Molecular Diversity. 4: 75-89. PMID 10425631 DOI: 10.1023/A:1026401917416  0.448
1998 Rowsell S, Stonehouse NJ, Convery MA, Adams CJ, Ellington AD, Hirao I, Peabody DS, Stockley PG, Phillips SE. Crystal structures of a series of RNA aptamers complexed to the same protein target. Nature Structural Biology. 5: 970-5. PMID 9808042 DOI: 10.1038/2946  0.44
1998 Convery MA, Rowsell S, Stonehouse NJ, Ellington AD, Hirao I, Murray JB, Peabody DS, Phillips SE, Stockley PG. Crystal structure of an RNA aptamer-protein complex at 2.8 A resolution. Nature Structural Biology. 5: 133-9. PMID 9461079 DOI: 10.1038/Nsb0298-133  0.44
1997 Peabody DS. Subunit fusion confers tolerance to peptide insertions in a virus coat protein. Archives of Biochemistry and Biophysics. 347: 85-92. PMID 9344468 DOI: 10.1006/Abbi.1997.0312  0.494
1997 Spingola M, Peabody DS. MS2 coat protein mutants which bind Qbeta RNA. Nucleic Acids Research. 25: 2808-15. PMID 9207028 DOI: 10.1093/Nar/25.14.2808  0.455
1997 Peabody DS. Role of the coat protein-RNA interaction in the life cycle of bacteriophage MS2. Molecular & General Genetics : Mgg. 254: 358-64. PMID 9180688 DOI: 10.1007/s004380050427  0.319
1996 Ni CZ, White CA, Mitchell RS, Wickersham J, Kodandapani R, Peabody DS, Ely KR. Crystal structure of the coat protein from the GA bacteriophage: model of the unassembled dimer. Protein Science : a Publication of the Protein Society. 5: 2485-93. PMID 8976557 DOI: 10.1002/Pro.5560051211  0.46
1996 Lim F, Spingola M, Peabody DS. The RNA-binding site of bacteriophage Qbeta coat protein. The Journal of Biological Chemistry. 271: 31839-45. PMID 8943226 DOI: 10.1074/Jbc.271.50.31839  0.452
1996 Peabody DS, Lim F. Complementation of RNA binding site mutations in MS2 coat protein heterodimers. Nucleic Acids Research. 24: 2352-9. PMID 8710507 DOI: 10.1093/Nar/24.12.2352  0.421
1995 Ni CZ, Syed R, Kodandapani R, Wickersham J, Peabody DS, Ely KR. Crystal structure of the MS2 coat protein dimer: implications for RNA binding and virus assembly. Structure (London, England : 1993). 3: 255-63. PMID 7788292 DOI: 10.1016/S0969-2126(01)00156-3  0.487
1994 Lim F, Peabody DS. Mutations that increase the affinity of a translational repressor for RNA. Nucleic Acids Research. 22: 3748-52. PMID 7937087 DOI: 10.1093/Nar/22.18.3748  0.443
1993 Pickett GG, Peabody DS. Encapsidation of heterologous RNAs by bacteriophage MS2 coat protein. Nucleic Acids Research. 21: 4621-6. PMID 8233800 DOI: 10.1093/Nar/21.19.4621  0.437
1993 Peabody D. The RNA binding site of bacteriophage MS2 coat protein. The Embo Journal. 12: 595-600. DOI: 10.1002/J.1460-2075.1993.Tb05691.X  0.489
1992 Peabody DS, Ely KR. Control of translational repression by protein-protein interactions. Nucleic Acids Research. 20: 1649-55. PMID 1579455 DOI: 10.1093/Nar/20.7.1649  0.451
1989 Peabody DS. Translational repression by bacteriophage MS2 coat protein does not require cysteine residues. Nucleic Acids Research. 17: 6017-27. PMID 2505229 DOI: 10.1093/Nar/17.15.6017  0.462
1988 Bear DG, Peabody DS. The E. coli Rho protein: an ATPase that terminates transcription. Trends in Biochemical Sciences. 13: 343-7. PMID 2977456 DOI: 10.1016/0968-0004(88)90104-1  0.338
Show low-probability matches.